Icon

IXEMPRA KIT (nda022065)- (15MG/VIAL,45MG/VIAL)

IXABEPILONE R-PHARM US LLC
15MG/VIAL,45MG/VIAL
Yes No
2025-Feb-21 2012-Oct-16
None None
None No
IXEMPRA is a microtubule inhibitor indicated for treatment: • In combination with capecitabine for patients with metastatic or locally advanced breast cancer after failure of an anthracycline and a taxane and for whom further anthracycline therapy is contraindicated. • As a single agent for patients with metastatic or locally advanced breast cancer after failure of an anthracycline, a taxane, and capecitabine.
0 0 0
Total Other Developers None
Drugs with Suitability No
15MG/VIAL ** ** - - -
45MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.